Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus vaginal suppositories for prevention of recurrent urinary tract infection in women
jRCTs061180053Completed
- Sponsor
- Ministry of Education, Culture, Sports, Science and Technology
- Start
- Feb 2014
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of Lactobacillus vaginal suppository in urinary tract infection (UTI) and cystitis, sponsored by Ministry of Education, Culture, Sports, Science and Technology. Primary endpoint: Primary response rate during 1-year administration. Started Feb 2014; status: completed.
02
Drugs
Lactobacillus vaginal suppository
03
Conditions
urinary tract infection (UTI)cystitis
Beyond the preview
Go deeper on jRCTs061180053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061180053.